thalidomide has been researched along with interleukin-8 in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 11 (50.00) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Dunzendorfer, S; Herold, M; Wiedermann, CJ | 1 |
| Nasca, MR; O'Toole, EA; Palicharla, P; West, DP; Woodley, DT | 1 |
| Hu, S; Lokensgard, JR; Peterson, PK; Sheng, WS; van Fenema, EM | 1 |
| Ashburner, BP; Baldwin, AS; Guttridge, DC; Keifer, JA | 1 |
| Fayyazi, A; Fiebig, T; Germann, T; Hecker, M; Lienenlüke, B; Stojanovic, T | 1 |
| Han, DS; Jin, SH; Kim, TI; Kim, WH; Shin, SK | 1 |
| Cunha, FQ; Ferreira, SH; Heluy-Neto, NE; Ramos, CD; Ribeiro, RA | 1 |
| Boiardi, A; Broggi, G; Corsini, E; Croci, D; Frigerio, S; Gelati, M; Pollo, B; Salmaggi, A; Silvani, A | 1 |
| Abrahamsen, MS; Maheswaran, SK; Malazdrewich, C; Thumbikat, P | 1 |
| Jung, HC; Kim, JS; Kim, YS; Song, IS | 1 |
| Inagaki, K; Kanayama, N; Kobayashi, H; Kondo, T; Kurita, N; Matsuzaki, H; Sekino, H; Suzuki, M; Terao, T; Wakahara, K; Yagyu, T | 1 |
| Andreassen, A; Aukrust, P; Breivik, K; Fjeld, JG; Frøland, SS; Følling, M; Gullestad, L; Gundersen, T; Hodt, A; Holt, E; Kjekshus, E; Kjekshus, J; Semb, AG; Skårdal, R; Ueland, T; Wergeland, R; Yndestad, A | 1 |
| Kamath, B; Noveck, R; Sandoval, F; Shannon, E | 1 |
| Begna, K; Finke, C; Lasho, T; Pardanani, A; Tefferi, A | 1 |
| Antonarakis, ES; Carducci, M; Drake, CG; Eisenberger, MA; Keizman, D; McNeel, DG; Smith, HA; Thoburn, CJ; Zabransky, DJ; Zahurak, M | 1 |
| Alfieri, C; Rance, E; Tanner, JE | 1 |
| Cheng, AL; Hsiao, CH; Hsu, C; Hsu, CH; Huang, CC; Lee, KD; Lin, ZZ; Lu, YS; Shao, YY; Shen, YC | 1 |
| Brown, NJ; Jitlal, M; Lee, SM; Tin, AW; Woll, PJ; Young, RJ | 1 |
| Amiot, M; Bonnaud, S; Gomez-Bougie, P; Gratas, C; Le Gouill, S; Maïga, S; Moreau, P; Pellat-Deceunynck, C | 1 |
| Agwa, HS; El-Aarag, BY; Kakuta, H; Kasai, T; Mizutani, A; Murakami, H; Sekhar, SC; Seno, M; Shigehiro, T; Zahran, MA; Zakhary, NI | 1 |
| Kataoka, S; Nakajima, K; Sano, S; Takaishi, M | 1 |
| Dobashi, H; Kadowaki, N; Kameda, T; Kato, M; Mino, R; Miyagi, T; Mizusaki, M; Nakashima, S; Shimada, H; Sugihara, K; Ueeda, K; Ushio, Y; Wakiya, R | 1 |
4 trial(s) available for thalidomide and interleukin-8
| Article | Year |
|---|---|
Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study.
Topics: Aged; Cardiomyopathy, Dilated; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Immune System; In Vitro Techniques; Interleukin-8; Matrix Metalloproteinase 2; Middle Aged; Placebos; Thalidomide; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left | 2005 |
Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Chemokine CCL2; Cytokines; Female; Humans; Interleukin-15; Interleukin-8; Janus Kinase 1; Janus Kinase 2; Male; Middle Aged; Mutation; Predictive Value of Tests; Primary Myelofibrosis; Receptors, Interleukin-2; Thalidomide; Treatment Outcome | 2011 |
Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antigens, Surface; Antineoplastic Agents; Biomarkers, Tumor; Disease Progression; Humans; Immunomodulation; Interleukin-8; Lenalidomide; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Thalidomide | 2012 |
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Disease Progression; Disease-Free Survival; Female; Hepatitis B virus; Humans; Interleukin-6; Interleukin-8; Liver Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Thalidomide; Treatment Outcome | 2012 |
18 other study(ies) available for thalidomide and interleukin-8
| Article | Year |
|---|---|
Inducer-specific bidirectional regulation of endothelial interleukin-8 production by thalidomide.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Chemotaxis, Leukocyte; Endothelium, Vascular; Humans; In Vitro Techniques; Interleukin-8; Lipopolysaccharides; Neutrophils; Thalidomide; Tumor Necrosis Factor-alpha | 1999 |
Thalidomide increases human keratinocyte migration and proliferation.
Topics: Cell Division; Cell Movement; Cell Survival; Gelatinases; Humans; Infant, Newborn; Interleukin-8; Keratinocytes; Male; Thalidomide | 1999 |
Effect of thalidomide on chemokine production by human microglia.
Topics: Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Chemokines; Enzyme-Linked Immunosorbent Assay; Humans; Immunosuppressive Agents; Interleukin-8; Lipopolysaccharides; Microglia; RNA, Messenger; Thalidomide | 2000 |
Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity.
Topics: Base Sequence; DNA Probes; Enzyme Inhibitors; Gene Expression Regulation; Humans; I-kappa B Kinase; Interleukin-1; Interleukin-8; Jurkat Cells; NF-kappa B; Protein Serine-Threonine Kinases; Thalidomide; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2001 |
Thalidomide impairment of trinitrobenzene sulphonic acid-induced colitis in the rat - role of endothelial cell-leukocyte interaction.
Topics: Animals; CD40 Ligand; Cell Adhesion; Colitis; Colon; Endothelium; Gene Expression Regulation; Humans; Interleukin-8; Leukocytes; Male; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Thalidomide; Trinitrobenzenesulfonic Acid; Vascular Cell Adhesion Molecule-1 | 2001 |
Thalidomide suppresses the interleukin 1beta-induced NFkappaB signaling pathway in colon cancer cells.
Topics: Colonic Neoplasms; Humans; Interleukin-1; Interleukin-8; NF-kappa B; Signal Transduction; Thalidomide; Tumor Cells, Cultured | 2002 |
Neutrophil migration induced by IL-8-activated mast cells is mediated by CINC-1.
Topics: Animals; Chemokine CXCL1; Chemokines; Chemokines, CXC; Chemotactic Factors; Chemotaxis, Leukocyte; Dexamethasone; Indoles; Indomethacin; Intercellular Signaling Peptides and Proteins; Interleukin-8; Male; Mast Cells; Neutrophils; Peritoneal Cavity; Rats; Rats, Wistar; Thalidomide | 2003 |
Effects of thalidomide on parameters involved in angiogenesis: an in vitro study.
Topics: Angiogenesis Inhibitors; Cell Division; Cells, Cultured; Endothelial Growth Factors; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; Integrin alphaVbeta3; Intercellular Signaling Peptides and Proteins; Interleukin-8; Lymphokines; Matrix Metalloproteinase 2; Neovascularization, Pathologic; Neovascularization, Physiologic; Receptors, Cell Surface; Thalidomide; Tumor Necrosis Factor-alpha; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitronectin | 2003 |
Pharmacological inhibition of Mannheimia haemolytica lipopolysaccharide and leukotoxin-induced cytokine expression in bovine alveolar macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cattle; Cells, Cultured; Cytokines; Dexamethasone; Exotoxins; Gene Expression Regulation; Imidazoles; Interleukin-1; Interleukin-8; Lipopolysaccharides; Macrophages, Alveolar; Mannheimia haemolytica; Pentoxifylline; Pyridines; RNA, Messenger; Rolipram; Tetrahydropapaveroline; Thalidomide; Tumor Necrosis Factor-alpha | 2004 |
The effects of thalidomide on the stimulation of NF-kappaB activity and TNF-alpha production by lipopolysaccharide in a human colonic epithelial cell line.
Topics: Cell Line; Colon; Epithelial Cells; Gene Expression Regulation; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-1; Interleukin-8; Lipopolysaccharides; NF-kappa B; RNA, Messenger; Thalidomide; Tumor Necrosis Factor-alpha | 2004 |
Thalidomide inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endometriotic stromal cells, possibly through suppression of nuclear factor-kappaB activation.
Topics: Active Transport, Cell Nucleus; Cells, Cultured; Endometriosis; Female; Humans; I-kappa B Proteins; Interleukin-8; NF-KappaB Inhibitor alpha; Stromal Cells; Thalidomide; Tosylphenylalanyl Chloromethyl Ketone; Tumor Necrosis Factor-alpha | 2005 |
Thalidomide suppressed IL-1beta while enhancing TNF-alpha and IL-10, when cells in whole blood were stimulated with lipopolysaccharide.
Topics: Adult; C-Reactive Protein; Cells, Cultured; Dexamethasone; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Interleukin-10; Interleukin-1beta; Interleukin-6; Interleukin-8; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Receptors, Tumor Necrosis Factor; Serum Amyloid A Protein; Thalidomide; Tumor Necrosis Factor-alpha | 2008 |
Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication.
Topics: Cell Line; Enzyme Inhibitors; Hepacivirus; Hepatocytes; Humans; I-kappa B Kinase; Interleukin-8; NF-kappa B; RNA, Viral; Thalidomide; Virus Replication | 2012 |
Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Deoxycytidine; Etoposide; Female; Fibroblast Growth Factor 2; Gemcitabine; Humans; Intercellular Adhesion Molecule-1; Interleukin-8; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Neovascularization, Pathologic; Proportional Hazards Models; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Survival Analysis; Thalidomide; Treatment Outcome; Vascular Endothelial Growth Factor A | 2012 |
Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Bone Marrow Cells; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Immunologic Factors; Insulin-Like Growth Factor I; Interleukin-8; Lenalidomide; Multiple Myeloma; Thalidomide; Tumor Necrosis Factor-alpha | 2013 |
In vitro anti-proliferative and anti-angiogenic activities of thalidomide dithiocarbamate analogs.
Topics: Angiogenesis Inhibitors; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Female; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; Interleukin-8; Matrix Metalloproteinase 2; Neovascularization, Pathologic; Nitric Oxide; Thalidomide; Thiocarbamates; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2014 |
Phosphodiesterase-4 inhibitors reduce the expression of proinflammatory mediators by human epidermal keratinocytes independent of intracellular cAMP elevation.
Topics: Aminopyridines; Benzamides; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Cyclic AMP; Cyclopropanes; Down-Regulation; Humans; Inflammation Mediators; Interleukin-18; Interleukin-1alpha; Interleukin-8; Keratinocytes; MAP Kinase Signaling System; Phosphodiesterase 4 Inhibitors; Psoriasis; Thalidomide; Tumor Necrosis Factor-alpha | 2020 |
Efficacy and safety of apremilast and its impact on serum cytokine levels in patients with Behçet's disease.
Topics: Behcet Syndrome; Cytokines; Humans; Interferon-gamma; Interleukin-10; Interleukin-23; Interleukin-6; Interleukin-8; Oral Ulcer; Thalidomide; Tumor Necrosis Factor-alpha | 2022 |